table of content
1 Introduction to Research & Analysis Reports
1.1 Non-small Cell Lung Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-small Cell Lung Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-small Cell Lung Cancer Drugs Overall Market Size
2.1 Global Non-small Cell Lung Cancer Drugs Market Size: 2022 VS 2030
2.2 Global Non-small Cell Lung Cancer Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-small Cell Lung Cancer Drugs Players in Global Market
3.2 Top Global Non-small Cell Lung Cancer Drugs Companies Ranked by Revenue
3.3 Global Non-small Cell Lung Cancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Non-small Cell Lung Cancer Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-small Cell Lung Cancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-small Cell Lung Cancer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Non-small Cell Lung Cancer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-small Cell Lung Cancer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-small Cell Lung Cancer Drugs Market Size Markets, 2022 & 2030
4.1.2 Biologics
4.1.3 Small Molecule Targeted Therapy
4.1.4 Chemotherapy
4.1.5 Other
4.2 By Type - Global Non-small Cell Lung Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Non-small Cell Lung Cancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Non-small Cell Lung Cancer Drugs Revenue, 2024-2030
4.2.3 By Type - Global Non-small Cell Lung Cancer Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-small Cell Lung Cancer Drugs Market Size, 2022 & 2030
5.1.2 Lung Adenocarcinoma
5.1.3 Squamous Cell Lung Carcinoma
5.1.4 Large-cell Lung Carcinoma
5.2 By Application - Global Non-small Cell Lung Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Non-small Cell Lung Cancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Non-small Cell Lung Cancer Drugs Revenue, 2024-2030
5.2.3 By Application - Global Non-small Cell Lung Cancer Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Non-small Cell Lung Cancer Drugs Market Size, 2022 & 2030
6.2 By Region - Global Non-small Cell Lung Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Non-small Cell Lung Cancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Non-small Cell Lung Cancer Drugs Revenue, 2024-2030
6.2.3 By Region - Global Non-small Cell Lung Cancer Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Non-small Cell Lung Cancer Drugs Revenue, 2018-2030
6.3.2 US Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.3.3 Canada Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.3.4 Mexico Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Non-small Cell Lung Cancer Drugs Revenue, 2018-2030
6.4.2 Germany Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.4.3 France Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.4.4 U.K. Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.4.5 Italy Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.4.6 Russia Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.4.8 Benelux Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Non-small Cell Lung Cancer Drugs Revenue, 2018-2030
6.5.2 China Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.5.3 Japan Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.5.4 South Korea Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.5.6 India Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Non-small Cell Lung Cancer Drugs Revenue, 2018-2030
6.6.2 Brazil Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.6.3 Argentina Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-small Cell Lung Cancer Drugs Revenue, 2018-2030
6.7.2 Turkey Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.7.3 Israel Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
6.7.5 UAE Non-small Cell Lung Cancer Drugs Market Size, 2018-2030
7 Non-small Cell Lung Cancer Drugs Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Non-small Cell Lung Cancer Drugs Major Product Offerings
7.1.4 AstraZeneca Non-small Cell Lung Cancer Drugs Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Major Product Offerings
7.3.4 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly and Company Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd
7.4.1 F. Hoffmann-La Roche Ltd Company Summary
7.4.2 F. Hoffmann-La Roche Ltd Business Overview
7.4.3 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc. Company Summary
7.5.2 Merck & Co., Inc. Business Overview
7.5.3 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Major Product Offerings
7.5.4 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Revenue in Global Market (2018-2023)
7.5.5 Merck & Co., Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
